SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-18-009725
Filing Date
2018-07-26
Accepted
2018-07-26 17:53:17
Documents
1
Period of Report
2018-07-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3121917gilliland_adial.html 3  
1 OWNERSHIP DOCUMENT f3121917gilliland_adial.xml 3 6389
  Complete submission text file 0001213900-18-009725.txt   8022
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address
Gilliland Robertson H. (Reporting) CIK: 0001718351 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38323 | Film No.: 18972684